US Edition
Miami-based Swift Sync’s novel heart pacing catheter is making its way through the FDA process - Refresh Miami
Summary by Refresh Miami
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Miami-based Swift Sync’s novel heart pacing catheter is making its way through the FDA process - Refresh Miami
Rick Toren wears a lot of hats. He’s a co-creator of the EpiPen, a former professor at the University of Miami (who’s looking to teach again) and the CEO of Swift Sync, which makes a pacing catheter for patients with heart problems. For Swift Sync, “what we want to do, after we get FDA approval, is build about 100 catheters and then put them into beta sites, so it proves that we can build them at scale, then deploy them and have them be used for…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
